Overview

 

Our BioPharmaceutical Services (BPS) offers a GLP laboratory that supports the pharmaceutical industry during the development of biologics and vaccines.  BPS testing capabilities include PK, Immunogenicity, cell based bio-assays and biomarkers with service offerings of assay development, GLP assay validation and sample analysis for both non-clinical and clinical specimens. 

 

AVANZA is known for superior quality, meeting and exceeding timelines, flexibility and responsiveness in a customer centric manner. Our experience includes being both a Prime and Subcontractor to the Government.

 

Our operation has been providing services to local as well as global biotechnology and drug development companies since the early 1990s. The majority of our scientific staff and Executives have more than 20 years of experience in the industry.

 

Expertise:

 

Ligand Binding Assays and Cell Based Assays:

• Development, Validation, Sample Analysis

• Pharmacokinetics

• Immunogenicity for vaccines: titer

• Toxin Neutralization assay: e.g. anthrax

• Immunogenicity for Biogolics: screen, confirm, titer

• Bioassay: cell based (e.g. Neutralizing Antibody assays) and non-cell based

• Biomarkers (single and multiplex)

• MSD – electrochemiluminescence

• ELISA – absorbance, fluorescence, luminescence, chemiluminescence

Facilities:

• 9,000 sq ft dedicated space for BPS (with potential adjacent expansion to 15,000 sq ft)

• Cryo and -80C freezers

• Back up generators

• REES^TM monitoring system

• Thermo Scientific Watson LIMS^TM 7.4

Major Equipment

• Meso Scale Discovery (MSD) SECTOR® Imager 2400 Systems

• BioTek ELx40^TM 5UCWS (Plate Washer)

• BioTek ELx50^TM (Plate Washer)

• BioTek ELx800^TM (Plate Washer)

• Molecular Devices (MDS) SpectraMax® M3 Multimode MicroPlate readers

• Taylor Wharton Liquid Nitrogen Systems

• Thermo/Forma^TM Scientific Steri-Cult CO₂ Incubator

Click here for a PDF version.